` 603566 (Pulike Biological Engineering Inc) vs Shanghai Composite Comparison - Alpha Spread

603566
vs
Shanghai Composite

Over the past 12 months, has underperformed Shanghai Composite, delivering a return of -32% compared to the Shanghai Composite's 9% growth.

Stocks Performance
603566 vs Shanghai Composite

Loading
603566
Shanghai Composite
Add Stock

Performance Gap
603566 vs Shanghai Composite

Loading
603566
Shanghai Composite
Difference

Performance By Year
603566 vs Shanghai Composite

Loading
603566
Shanghai Composite
Add Stock

Competitors Performance
Pulike Biological Engineering Inc vs Peers

Shanghai Composite
603566
LLY
JNJ
NOVO B
ROG
Add Stock

Pulike Biological Engineering Inc
Glance View

Market Cap
4.3B CNY
Industry
Pharmaceuticals

Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.

Intrinsic Value
17.35 CNY
Undervaluation 28%
Intrinsic Value
Price
P
Back to Top